| Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960) |
|---|
| 09/09/2009 | CN101528754A Therapeutic methods using WRN binding molecules |
| 09/09/2009 | CN101525339A Novel oxabispidine compounds and their use in the treatment of cardiac arrhythmias |
| 09/09/2009 | CN100537519C Intermediate for preparing benzo-oxazine derivative and its preparing method |
| 09/08/2009 | US7585975 A group is bonded to at least one of the carbons at the 5, 6, 7 or 8 position of the bicyclic ring, and the ring is substituted by up to three independent R3 groups. The invention also includes methods of using these compounds as type I receptor tyrosine kinase inhibitors and hyperproliferation diseases |
| 09/08/2009 | US7585972 (9S-(9 alpha ,10 beta ,12 alpha ))-2,3,9,10,11,12-hexahydro-10-hydroxy-10-(methoxycarbonyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-k1]pyrrolo[3,4-i][1,6]benzodiazocin-1-one bis(tetrahydrofuranate) |
| 09/08/2009 | US7585860 Substituted oxazolidinones and their use in the field of blood coagulation |
| 09/08/2009 | CA2319032C New cytotoxic tris(oxazole)-containing macrolides |
| 09/08/2009 | CA2316388C Tetrahydrobenzindole derivative |
| 09/03/2009 | WO2009108766A1 Gamma secretase modulators for the treatment of alzheimer ' s disease |
| 09/03/2009 | WO2009108722A2 Substituted benzoxazinones |
| 09/03/2009 | WO2009107850A2 Fused heterocyclic derivative and use thereof |
| 09/03/2009 | WO2009106967A1 Novel 7-substituted derivatives of 3-carboxy-oxadiazino-quinolones, preparation thereof and use thereof as anti-bacterial agents |
| 09/03/2009 | WO2009082437A3 Selective androgen receptor modulators (sarms) and uses thereof |
| 09/03/2009 | US20090221827 Processes for the preparation of different forms of (s)-(+)-clopidogrel besylate |
| 09/03/2009 | US20090221699 Fab I Inhibitors |
| 09/03/2009 | US20090221565 8-Fluoro-3-methyl-6-oxo-9-[(R)-3-(thiazol-2-ylamino)-pyrrolidin-1-yl]-2,3-dihydro-6H-1-oxa-3,3a-diaza-phenalene-5-carboxylic acid; can be solid or liquid |
| 09/03/2009 | US20090221551 Substituted fused[1,2] imidazo[4,5c] ring compounds and methods |
| 09/03/2009 | US20090221519 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 09/03/2009 | US20090221503 Use of rapamycin and rapamycin derivatives for the treatment of bone loss |
| 09/03/2009 | CA2716773A1 Fused heterocyclic derivative and use thereof |
| 09/03/2009 | CA2716747A1 Gamma secretase modulators for the treatment of alzheimer's disease |
| 09/03/2009 | CA2715728A1 Novel 7-substituted derivatives of 3-carboxy-oxadiazino-quinolone, prep aration thereof and use thereof as anti-bacterials |
| 09/02/2009 | EP2094713A1 Epothilone analogues modified at positions c12-c13 as anticancer drugs |
| 09/02/2009 | EP2094671A1 Heterobicyclic metalloprotease inhibitors |
| 09/02/2009 | EP1458392B1 Acridones as inhibitors of impdh enzyme |
| 09/02/2009 | EP1300395B1 4-substituted piperidine compound |
| 09/02/2009 | CN101522691A Process for producing o-alkylated rapamycin derivative, and o-alkylated rapamycin derivative |
| 09/02/2009 | CN101522690A Crystalline forms of rapamycin analogs |
| 09/02/2009 | CN101522689A Pyridooxazepine progesteron receptor modulators |
| 09/02/2009 | CN101519361A Preparation process of lavo-ofloxacin and ofloxacin |
| 09/01/2009 | US7582659 effective against aerobic and anerobic pathogens such as multi-resistant staphylococci, streptococci and enterococci; 1-[5(R)-3-[4-[2-[(1 alpha ,5 alpha ,6 beta )-6-Cyano-3-azabicyclo[3.1.0]hexan-6-yl]pyridin-5-yl]-3-fluorophenyl]-2-oxooxazolidin-5-ylmethyl]-1,2,3-triazole; side effect reduction |
| 09/01/2009 | US7582648 Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 09/01/2009 | US7582627 3-aminoquinazolin-2,4-dione antibacterial agents |
| 09/01/2009 | CA2467973C Pyridine derivatives as nmda receptor ligands |
| 09/01/2009 | CA2390770C H-annellated benzo[f]chromenes |
| 09/01/2009 | CA2183381C Asymmetric triphenylenedioxazine compounds |
| 08/27/2009 | US20090215795 Cyclic amidine derivatives |
| 08/27/2009 | US20090215766 Tetracyclic inhibitors of janus kinases |
| 08/27/2009 | US20090215763 Substituted benzoxazinones |
| 08/27/2009 | US20090215761 Quinobenzoxazine analogs and methods of using thereof |
| 08/27/2009 | US20090215747 Heterocyclic compounds as inhibitors of beta-lactamases |
| 08/27/2009 | US20090215743 Tricyclic benzazepine derivatives and their use |
| 08/27/2009 | US20090215742 Amide resorcinol compounds |
| 08/27/2009 | US20090215712 Pyrazole derivatives |
| 08/27/2009 | CA2713182A1 Azatricyclic antibiotic compounds |
| 08/26/2009 | EP2093220A2 Inhibitors of fatty acid amide hydrolase |
| 08/26/2009 | EP2091953A1 8-sulfonyl-l, 3, 4, 8-tetrahydr0-2h- [1, 4]oxazepino [6, 7-e]indole derivatives and their use as 5-ht6 receptor ligands |
| 08/26/2009 | EP1745033A4 4,5-disubstituted-2-aryl pyrimidines |
| 08/26/2009 | CN101516892A Process for preparing n-alkyl naltrexone halides |
| 08/26/2009 | CN101516889A Derivatives and analogs of n-ethylquinolones and n-ethylazaquinolones |
| 08/26/2009 | CN101516879A Preparation and utility of substituted imidazopyridine compounds with hypnotic effects |
| 08/26/2009 | CN101516860A Benzoxazoles and oxazolopyridines being useful as FANUS kinases inhibitors |
| 08/26/2009 | CN101516850A Heteroaryl compounds useful as inhibitors of E1 activating enzymes |
| 08/26/2009 | CN101514208A Green synthesizing process for ofloxacin |
| 08/26/2009 | CN101514191A Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 08/26/2009 | CN100532495C Double functional photochromism compound with stable nitrogen-oxygen free radical group and spiro oxazinyl and synthetic method and use thereof |
| 08/25/2009 | US7579478 Process for the purification of substituted benzoxazole compounds |
| 08/25/2009 | US7579472 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones |
| 08/25/2009 | US7579345 e.g. 4-[cyano(di-2-thienyl)methyl]-1-[3-(phenyloxy)propyl]-1-azoniabicyclo[2.2.2]octane bromide; muscle relaxants, respiratory system disorders; asthma, emphysema, bronchitis, chronic obstructive lung disease, chronic bronchitis, chronic respiratory obstruction, pulmonary fibrosis, pulmonary fibrosis |
| 08/25/2009 | US7579344 Pyrimidine derivatives possessing cell-cycle inhibitors activity |
| 08/25/2009 | US7579337 Analogs of benzoquinone-containing ansamycins and methods of use thereof |
| 08/25/2009 | CA2383466C Aromatic nitrogen-containing 6-membered cyclic compounds |
| 08/20/2009 | WO2009100872A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 08/20/2009 | WO2009100536A1 Inhibitors of kinase activity with 1,2-di-cyclyl substituted alkyne structures |
| 08/20/2009 | WO2009075744A3 Curable benzoxazine-based compositions, their preparation and cured products thereof |
| 08/20/2009 | US20090209566 Spirocyclic Compounds |
| 08/20/2009 | US20090209549 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof |
| 08/20/2009 | US20090209547 C-8 halogenated macrolides |
| 08/20/2009 | US20090209544 Aminotetrahydropyrans as Dipeptidyl Peptidase-IV Inhibitors for the Treatment or Prevention of Diabetes |
| 08/20/2009 | US20090208590 Analogs of Benzoquinone-Containing Ansamycins and Methods of Use Thereof |
| 08/20/2009 | CA2711757A1 Urea derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 08/19/2009 | EP2090580A1 Process for producing o-alkylated rapamycin derivative, and o-alkylated rapamycin derivative |
| 08/19/2009 | EP2090577A2 Heteroaryl compounds, compositions thereof, and their use as protein kinase inhibitors |
| 08/19/2009 | EP2090576A1 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators |
| 08/19/2009 | EP2089385A2 Inhibitors of hepatitis c virus |
| 08/19/2009 | EP2089369A2 2,4 -pyrimidinediamine derivatives as inhibitors of jak kinases for the treatment of autoimmune diseases |
| 08/19/2009 | EP2089020A1 Macrocyclic peptides as hepatitis c virus inhibitors |
| 08/19/2009 | EP1794166B1 Polymeric/oligomeric methacrylate functionalized amide acetals in coatings |
| 08/19/2009 | CN101511845A Spiro antibiotic derivatives |
| 08/19/2009 | CN101508696A 2-methyl-5-imidogen-benzo[d][1,3] oxazine[5-b] pyrazole compound, preparation method and application thereof |
| 08/19/2009 | CN100528154C Malonyl-COA decarboxylase inhibitors useful as metabolic modulators |
| 08/18/2009 | US7576111 Substituted oxazolidinones and their use in the field of blood coagulation |
| 08/18/2009 | US7576079 Viral polymerase inhibitors |
| 08/18/2009 | US7576074 Receptor-type kinase modulators and methods of use |
| 08/18/2009 | US7576072 Heterocyclic inhibitors of MEK and methods of use thereof |
| 08/18/2009 | CA2427831C Cyclization process step in the making of quinolones and naphthyridines |
| 08/13/2009 | WO2009099982A1 2-aminopyridine kinase inhibitors |
| 08/13/2009 | WO2009099929A1 Mesoionic pesticides |
| 08/13/2009 | WO2009099741A1 Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods |
| 08/13/2009 | WO2009099736A2 Benzoxazole carboxamide inhibitors of poly(adp-ribose)polymerase (parp) |
| 08/13/2009 | WO2009098448A1 Compounds |
| 08/13/2009 | US20090204204 Drug/Drug Deliver Systems For The Prevention And Treatment Of Vascular Disease |
| 08/13/2009 | US20090202536 Antibody-drug conjugates and methods |
| 08/13/2009 | CA2714181A1 Ampk modulators |
| 08/13/2009 | CA2713347A1 Mesoionic pesticides |
| 08/13/2009 | CA2713322A1 Compounds |
| 08/12/2009 | EP2086982A1 Hcv ns3 protease inhibitors |
| 08/12/2009 | EP2086980A1 Macrocyclic peptides as hepatitis c virus inhibitors |
| 08/12/2009 | EP2086967A2 Inhibitors of hepatitis c virus |
| 08/12/2009 | EP1601354A4 Oxadiazoline ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |